Latest Equities News

Viva Energy announces the resignation of Jevan Bouzo as CEO of its Convenience and Mobility business, appointing Jennifer Gray as interim leader while searching for a permanent replacement.

JAYRIDE Group Limited has confirmed Randy Prado as CEO and Ram Navaratnam as Finance Director, cementing leadership as it advances its SaaS mobility platform with pilots in Southeast Asia.

Kogan.com Ltd has announced a fully franked ordinary dividend of 7 cents per share for the six months ending June 2025, alongside details of its Dividend Reinvestment Plan pricing.

Scout Security reports a significant 48% reduction in operating cash outflows for the June quarter, while holding just $78,000 in cash and advancing talks to acquire Roo Inc. The company is navigating funding challenges amid an ongoing ASX trading suspension.

Scout Security reported a significant 62% reduction in operating cash outflows for Q3 FY2025, while advancing a potential acquisition and partnership opportunities following CES. The company’s cash position remains tight, prompting ongoing capital raising efforts.

Scout Security reports a 52% jump in quarterly cash receipts and a 31% reduction in operating outflows, while advancing plans to acquire New York’s Roo Inc.

Equinox Resources has agreed to sell its Alturas Antimony Project in British Columbia to Maxus Mining, freeing up capital and focus for its core iron ore ambitions in Western Australia.

Generation Development Group Limited has updated its Dividend Reinvestment Plan price to AUD 6.70 per share, accompanying a fully franked ordinary dividend of 1 cent per share for the half-year ending June 2025.

Leo Lithium has announced a significant $330 million return to shareholders in 2025, following the termination of its asset acquisition strategy and a decision to monetise remaining assets.

Andromeda Metals' latest Scoping Study reveals a compelling economic case for its innovative High Purity Alumina (HPA) production technology, highlighting strong returns and a significant carbon emissions advantage. The project aims to meet soaring global demand with a 10,000 tonne per annum facility in South Australia.

Neurizon Therapeutics has locked in a significant R&D tax incentive advance covering overseas and domestic development costs for its lead ALS drug candidate NUZ-001, accelerating its clinical progress with a $5.6 million rebate expected in 2025.

Revolution Private Credit Income Trust has released comprehensive rules for its Distribution Reinvestment Plan, outlining how investors can reinvest distributions into additional units. The plan details eligibility, pricing, and operational procedures, setting the stage for potential shifts in investor participation and capital structure.